Sulfuric Acid

Sulfuric Acid

SCHEMBL6535324

Cl.O=S(=O)(O)O.[AlH3].[CaH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28724820 0.95
Sulfuric Acid SCHEMBL28543631 0.95
Sulfuric Acid SCHEMBL28174424 0.95 CA5A (0.60)
Sulfuric Acid SCHEMBL28174427 0.95
Sulfuric Acid SCHEMBL4295446 0.94
Sulfuric Acid SCHEMBL28448610 0.94
Sulfuric Acid SCHEMBL8160868 0.94 CA5A (0.75)
Sulfuric Acid SCHEMBL4961900 0.94 CA5A (0.75)
Sulfuric Acid SCHEMBL17330339 0.94 CA5A (0.75)
Sulfuric Acid SCHEMBL599532 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109502617-A Basic aluminium chloride solution and its manufacturing method 中央硝子株式会社 2019-03-22 CN disclosed
EP-1030547-B1 METHODS FOR PREVENTING AND TREATING BACTERIAL INFECTIONS USING CELLULOSE ACETATE PHTHALATE OR HYDROXYPROPYL METHYLCELLULOSE PHTHALATE EXCIPIENTS NEW YORK BLOOD CT INC (US) 2004-12-15 EP disclosed
EP-0851783-A4 NOVEL AROMATIC AND ALIPHATIC SULFONATES AND PROPERTIES AND APPLICATIONS THEREOF AKZO NOBEL SURFACE CHEM (SE) 2004-01-02 EP disclosed
WO-2003075788-A2 BIODEGRADABLE MICROBICIDAL VAGINAL BARRIER DEVICE NEW YORK BLOOD CENTER, INC. (US) 2003-09-18 WO disclosed
US-6596297-B2 Bio-erodible microbicidal devices for prevention of sexually transmitted diseases; retains antiviral activity at neutral pH and thus does not lose activity in the presence of seminal fluid; vaginal sponge with built-in microbicidal activity NEW YORK BLOOD CENTER, INC. 2003-07-22 US disclosed
US-6572875-B2 Micronized compound selected from the group consisting of cellulose acetate phthalate and hydroxypropylmethylcellulose phthalate; and a water soluble cellulose compound; foaming, freezing and freeze-drying NEW YORK BLOOD CENTER, INC. 2003-06-03 US disclosed
EP-1030547-A4 METHODS FOR PREVENTING AND TREATING BACTERIAL INFECTIONS USING CELLULOSE ACETATE PHTHALATE OR HYDROXYPROPYL METHYLCELLULOSE PHTHALATE EXCIPIENTS NEW YORK BLOOD CT INC (US) 2002-11-06 EP disclosed
US-6462030-B1 MICROBIOCIDES TO MYCOPLASMA HOMINIS, MYCOPLASMA CAPRICOLUM, MOBILUNCUS CURTISII AND PREVOTELLA CORPORIS NEW YORK BLOOD CENTER, INC. 2002-10-08 US disclosed
US-20020127276-A1 Biodegradable microbicidal vaginal barrier device NEW YORK BLOOD CENTER, INC. 2002-09-12 US disclosed
US-20020076430-A1 Biodegradable microbicidal vaginal barrier device NEW YORK BLOOD CENTER, INC. 2002-06-20 US disclosed
WO-2002036055-A1 BIODEGRADABLE MICROBICIDAL VAGINAL BARRIER DEVICE NEW YORK BLOOD CENTER, INC. (US) 2002-05-10 WO disclosed
WO-2001005377-A1 METHOD FOR INACTIVATING BACTERIA ASSOCIATED WITH BACTERIAL VAGINOSIS USING CELLULOSE ACETATE PHTHALATE AND/OR HYDROXYPROPYL METHYLCELLULOSE PHTHALATE NEW YORK BLOOD CENTER, INC. (US) 2001-01-25 WO disclosed
US-6165493-A \"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections\ NEW YORK BLOOD CENTER, INC. (US) 2000-12-26 US disclosed
EP-1030547-A1 METHODS FOR PREVENTING AND TREATING BACTERIAL INFECTIONS USING CELLULOSE ACETATE PHTHALATE OR HYDROXYPROPYL METHYLCELLULOSE PHTHALATE EXCIPIENTS New York Blood Center, Inc. (US) 2000-08-30 EP disclosed
US-5985313-A Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients NEW YORK BLOOD CENTER, INC. (US) 1999-11-16 US disclosed
WO-1999020098-A1 METHODS FOR PREVENTING AND TREATING BACTERIAL INFECTIONS USING CELLULOSE ACETATE PHTHALATE OR HYDROXYPROPYL METHYLCELLULOSE PHTHALATE EXCIPIENTS NEW YORK BLOOD CENTER, INC. (US) 1999-04-29 WO disclosed
EP-0851783-A1 NOVEL AROMATIC AND ALIPHATIC SULFONATES AND PROPERTIES AND APPLICATIONS THEREOF CK WITCO CORPORATION (US) 1998-07-08 EP disclosed
WO-1997045186-A1 NOVEL AROMATIC AND ALIPHATIC SULFONATES AND PROPERTIES AND APPLICATIONS THEREOF WITCO CORPORATION (US) 1997-12-04 WO disclosed
EP-0273445-B1 CHEMICAL GROUT FOR GROUND INJECTION AND METHOD FOR ACCRETION NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-05-20 EP disclosed